Moderna study suggests half doses offer strong immune response, but experts caution against changing approach

There’s now early evidence showing Moderna’s coronavirus vaccine may elicit a strong immune response even through half doses, prompting hope that further research could back up the results and eventually allow countries like Canada to stretch out vaccine supplies.